Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa)

被引:0
|
作者
Zhang, L [1 ]
Schaner, ME [1 ]
Giacomini, KM [1 ]
机构
[1] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recently, a polyspecific organic cation transporter, hOCT1, was cloned from human liver. To date, limited studies examining the functional characteristics of the transporter have been performed. The purpose of the present study was to develop a mammalian expression system for hOCT1 and to characterize the interactions of various compounds with the cloned transporter. Lipofection was used to transiently transfect the hOCT1 plasmid DNA in a human cell line, HeLa. We tested the interaction of an array of organic cations and other compounds with hOCT1 by determining K-i values in inhibiting C-14-tetraethylammonium (TEA) transport in the transfected cells. Transient expression of hOCT1 activity was observed between 24 and 72 hr post-transfection, with maximal expression at approximately 40 hr. TEA transport was temperature dependent and saturable with V-max and K-m values of 2.89 +/- 0.448 nmol/mg protein/30 min and 229 +/- 78.4 mu M, respectively. C-14-TEA uptake in hOCT1 plasmid DNA-transfected HeLa cells was trans-stimulated by unlabeled TEA and 1-methyl-4-phenyl-pyridinium. Organic cations, including clonidine, quinine, quinidine and verapamil (0.1 mM), significantly inhibited C-14-TEA uptake, whereas the organic anion, p-aminohippuric acid (5 mM), did not. The neutral compounds, corticosterone (K-i, 7.0 mu M) and midazolam (Ki, 3.7 mu M) potently inhibited 14C-TEA uptake. The K-i values of several compounds in interacting with hOCT1 differed substantially from the corresponding values for the rat organic cation transporter, rOCT1, and the human kidney-specific organic cation transporter, hOCT2, determined in previous studies. Transiently transfected HeLa cells represent a useful tool in studying the interactions and kinetics of organic cations and other xenobiotics with hOCT1 and in understanding the molecular events involved in organic cation transport.
引用
收藏
页码:354 / 361
页数:8
相关论文
共 50 条
  • [1] Functional characterization of a human organic cation transporter (hOCT1) in a mammalian cell line (HeLa)
    Zhang, L
    Schaner, ME
    Giacomini, KM
    [J]. FASEB JOURNAL, 1998, 12 (05): : A1017 - A1017
  • [2] Imatinib and human organic cation transporter 1 (hOCT1): Characterisation of transport in a stably transfected myeloid cell line, and relationship of hOCT1 expression to cytogenetic response
    Wang, Lihui
    Giannoudis, Athina
    Pirmohamed, Munir
    Clark, Richard E.
    [J]. DRUG METABOLISM REVIEWS, 2006, 38 : 118 - 118
  • [3] Regulation of the human organic cation transporter hOCT1
    Ciarimboli, G
    Struwe, K
    Arndt, P
    Gorboulev, V
    Koepsell, H
    Schlatter, E
    Hirsch, JR
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2004, 201 (03) : 420 - 428
  • [4] Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences
    Kerb, R
    Brinkmann, U
    Chatskaia, N
    Gorbunov, D
    Gorboulev, V
    Mornhinweg, E
    Keil, A
    Eichelbaum, M
    Koepsell, H
    [J]. PHARMACOGENETICS, 2002, 12 (08): : 591 - 595
  • [5] Identification of compounds that interact with the human organic cation transporter 1 (hOCT1)
    Gustavsson, Lena
    Lohmann, Christina
    Hollnack, Evelyn
    Steinwall, Johanna
    Gelius, Birgitta
    Danielsson, Jeanette
    Skoging-Nyberg, Ulrica
    Wahlberg, Johanna
    Hoogstraate, Janet
    [J]. DRUG METABOLISM REVIEWS, 2006, 38 : 117 - 117
  • [6] The expression of the human organic cation transporter hOCT1 in mammary gland.
    Dhillon, U
    Shenton, J
    Cook, V
    Harper, P
    Watson-Macdonell, J
    Ito, S
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 205 - 205
  • [7] Tissue specific expression of variants of the human organic cation transporter (hOCT1)
    Hayer, M
    Brüss, M
    Bönisch, H
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R413 - R413
  • [8] The function and expression of the human organic cation transporter hOCT1 in mammary gland
    Dhillon, U
    Cook, V
    Harper, P
    Watson-MacDonell, J
    Ito, S
    [J]. FASEB JOURNAL, 1999, 13 (04): : A402 - A402
  • [9] Pharmacophore modelling of stereoselective binding to the human organic cation transporter (hOCT1)
    Moaddel, R.
    Ravichandran, S.
    Bighi, F.
    Yamaguchi, R.
    Wainer, I. W.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (08) : 1305 - 1314
  • [10] Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1
    Bednarczyk, D
    Ekins, S
    Wikel, JH
    Wright, SH
    [J]. MOLECULAR PHARMACOLOGY, 2003, 63 (03) : 489 - 498